Hi George,
We don’t know, but they are new sub-analyses being presented by Janssen from the CREDENCE trial. PIQ were looking at CKD & whether PromarkerD can predict cardiovascular disease also from past ANNs.
Here is the link where you can view slides from presentations & they will come out after they are presented (as per times & dates in your post).
https://www.acc.org/latest-in-cardiology/features/meeting-coverage/2020/acc-2020-meeting-coverage
There may be some clues there, I really hope so.
Regarding Janssen presentation this weekend., page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.65M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.0¢ | 38.0¢ | $98.01K | 252.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9722 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 44999 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |